In comparison with age‐matched control tissue, demyelinated human MS lesions show increased numbers of SOX2+ cells (a marker of neural progenitors) co‐expressing p16INK4a, suggesting the presence of senescent progenitor cells in progressive MS [159]. This evidence concerns the gene CDKN2A and myeloid sarcoma.